The MRD Study is evaluating an investigational immunotherapy combined with traditional standard of care (chemotherapy, BEV and surgery) treatment, compared to standard of care treatment alone, in women with newly diagnosed or suspected late-stage ovarian cancer.

*Standard of care treatment — Standard of care, or best practice, is a guideline for the appropriate treatment of a condition, as established by formal or informal consensus among experts on that condition. Basically, the standard of care for the treatment of a disease is whatever most physicians agree is the best way to treat that disease.